Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 1 » Issue 4

Effect of bronchodilatation on single breath pulmonary uptake of carbon monoxide in chronic obstructive pulmonary disease

Authors Simonetta Baldi, Claudio Fracchia, Claudio Bruschi, Roberto Dore, Roberto Maestri, et al

Published 15 January 2007 Volume 2006:1(4) Pages 477—483



Simonetta Baldi1, Claudio Fracchia1, Claudio Bruschi1, Roberto Dore2, Roberto Maestri1, Vito Brusasco3, Riccardo Pellegrino4

1U.O di Riabilitazione Specialistica Pneumologia Riabilitativa, Istituto Scientifico di Montescano, Fondazione Salvatore Maugeri IRCCS, 27040 Montescano, Pavia; 2Istituto di Radiologia Medica, Policlinico S. Matteo IRCCS, 27100, Pavia; 3Dipartimento di Medicina Interna, Università di Genova, 16132 Genova; 4Centro di Fisiopatologia Respiratoria e di Studio della Dispnea, Azienda Ospedaliera S.Croce e Carle, 12100 Cuneo; Italy

Abstract: We studied 21 COPD patients in stable clinical conditions to evaluate whether changes in lung function induced by cumulative doses of salbutamol alter diffusing capacity for carbon monoxide (DLCO), and whether this relates to the extent of emphysema as assessed by high resolution computed tomography (HRCT) quantitative analysis. Spirometry and DLCO were measured before and after cumulative doses of inhaled salbutamol (from 200 µg to 1000 µg). Salbutamol caused significant increments of forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and flows at 30% of control FVC taken from both partial and maximal forced expiratory maneuvers. Functional residual capacity and residual volume were reduced, while total lung capacity did not change significantly. DLCO increased progressively with the incremental doses of salbutamol, but this became significant only at the highest dose (1000 µg) and was independent of the extent of emphysema, as assessed by radiological parameters. No significant changes were observed in CO transfer factor (DLCO/VA) and alveolar volume (VA). The results suggest that changes in lung function induced by cumulative doses of inhaled salbutamol are associated with a slight but significant increase in DLCO irrespective of the presence and extent of emphysema.

Keywords: lung volumes, high resolution computed tomography, chronic obstructive bronchitis, emphysema